Literature DB >> 19586939

Changes in cytokine profile pre- and post-immunosuppression in acquired aplastic anemia.

Carlo Dufour1, Elisa Ferretti, Francesca Bagnasco, Oriana Burlando, Marina Lanciotti, Ugo Ramenghi, Paola Saracco, Maria Teresa Van Lint, Daniela Longoni, Giovanni Fernando Torelli, Marta Pillon, Anna Locasciulli, Aldo Misuraca, Milena La Spina, Andrea Bacigalupo, Vito Pistoia, Anna Corcione, Johanna Svahn.   

Abstract

Cytokine expression assessed by flow cytometry in 53 acquired aplastic anemia patients before and after combined immunosuppression (EBMT WPSAA protocols) showed that CD3(+) marrow cells containing TNF-alpha, IFN-gamma and IL4 were similar in subjects with disease at onset (DO) and responsive to treatment who had more CD3(+)/TNF-alpha(+) and CD 3(+)/IFN-gamma(+) cells than normal controls. In vitro block of TNF-alpha and/or IFN-gamma significantly increased BFU-e over baseline in 28 patients. In responsive to treatment patients only TNF-alpha block significantly incremented colonies over normal controls. Absolute marrow CD3(+)/TNF-alpha(+) and CD3(+)/IFN-gamma(+) cells prospectively tested in a group of 21 subjects declined significantly more in Responders than in Non Responders to immunosuppression at Response Evaluation Time respect to Diagnosis. Both in Responders and in Non Responders these cells remained higher than in normal controls. This study suggests that immunosuppression does not fully clear excess TNF-alpha and IFN-gamma from marrow of patients with good outcome and raises the hypothesis that additional cytokine blockade might be useful in immunosuppression for acquired aplastic anemia.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19586939      PMCID: PMC2791951          DOI: 10.3324/haematol.2009.007815

Source DB:  PubMed          Journal:  Haematologica        ISSN: 0390-6078            Impact factor:   9.941


  17 in total

Review 1.  Hematopoietic cell destruction by immune mechanisms in acquired aplastic anemia.

Authors:  N S Young
Journal:  Semin Hematol       Date:  2000-01       Impact factor: 3.851

2.  Severe aplastic anemia: a prospective study of the effect of early marrow transplantation on acute mortality.

Authors:  B M Camitta; E D Thomas; D G Nathan; G Santos; E C Gordon-Smith; R P Gale; J M Rappeport; R Storb
Journal:  Blood       Date:  1976-07       Impact factor: 22.113

3.  Interferon gamma and tumour necrosis factor alpha are overexpressed in bone marrow T lymphocytes from paediatric patients with aplastic anaemia.

Authors:  C Dufour; A Corcione; J Svahn; R Haupt; N Battilana; V Pistoia
Journal:  Br J Haematol       Date:  2001-12       Impact factor: 6.998

4.  Aplastic anemia: presence in human bone marrow of cells that suppress myelopoiesis.

Authors:  W A Kagan; J A Ascensão; R N Pahwa; J A Hansen; G Goldstein; E B Valera; G S Incefy; M A Moore; R A Good
Journal:  Proc Natl Acad Sci U S A       Date:  1976-08       Impact factor: 11.205

5.  Lymphokine overproduction in severe aplastic anemia is not related to blood transfusions.

Authors:  W Hinterberger; G Adolf; P Bettelheim; K Geissler; C Huber; E Irschick; P Kalhs; U Köller; K Lechner; B Meister
Journal:  Blood       Date:  1989-12       Impact factor: 22.113

6.  Role for granulocyte colony-stimulating factor in the generation of human T regulatory type 1 cells.

Authors:  Sergio Rutella; Luca Pierelli; Giuseppina Bonanno; Simona Sica; Franco Ameglio; Ettore Capoluongo; Andrea Mariotti; Giovanni Scambia; Giuseppe d'Onofrio; Giuseppe Leone
Journal:  Blood       Date:  2002-10-01       Impact factor: 22.113

7.  Prospective multicenter trial comparing repeated immunosuppressive therapy with stem-cell transplantation from an alternative donor as second-line treatment for children with severe and very severe aplastic anemia.

Authors:  Yoshiyuki Kosaka; Hiroshi Yagasaki; Kimihiko Sano; Ryoji Kobayashi; Hiroshi Ayukawa; Takashi Kaneko; Hiromasa Yabe; Masahiro Tsuchida; Hideo Mugishima; Akira Ohara; Akira Morimoto; Yoshitoshi Otsuka; Shouichi Ohga; Fumio Bessho; Tatsutoshi Nakahata; Ichiro Tsukimoto; Seiji Kojima
Journal:  Blood       Date:  2007-11-07       Impact factor: 22.113

8.  Intracellular interferon-gamma in circulating and marrow T cells detected by flow cytometry and the response to immunosuppressive therapy in patients with aplastic anemia.

Authors:  Elaine Sloand; Sonnie Kim; Jaroslaw P Maciejewski; John Tisdale; Dean Follmann; Neal S Young
Journal:  Blood       Date:  2002-08-15       Impact factor: 22.113

9.  TNF-alpha and IFN-gamma are overexpressed in the bone marrow of Fanconi anemia patients and TNF-alpha suppresses erythropoiesis in vitro.

Authors:  Carlo Dufour; Anna Corcione; Johanna Svahn; Riccardo Haupt; Vincenzo Poggi; Albert Nandor Béka'ssy; Rosanna Scimè; Angela Pistorio; Vito Pistoia
Journal:  Blood       Date:  2003-05-15       Impact factor: 22.113

10.  Relapse of aplastic anaemia after immunosuppressive treatment: a report from the European Bone Marrow Transplantation Group SAA Working Party.

Authors:  H Schrezenmeier; P Marin; A Raghavachar; S McCann; J Hows; E Gluckman; C Nissen; E T van't Veer-Korthof; P Ljungman; W Hinterberger
Journal:  Br J Haematol       Date:  1993-10       Impact factor: 6.998

View more
  14 in total

Review 1.  The diagnosis and treatment of aplastic anemia: a review.

Authors:  Maurizio Miano; Carlo Dufour
Journal:  Int J Hematol       Date:  2015-04-03       Impact factor: 2.490

2.  Necroptosis in spontaneously-mutated hematopoietic cells induces autoimmune bone marrow failure in mice.

Authors:  Junping Xin; Peter Breslin; Wei Wei; Jing Li; Rafael Gutierrez; Joseph Cannova; Allen Ni; Grace Ng; Rachel Schmidt; Haiyan Chen; Vamsi Parini; Paul C Kuo; Ameet R Kini; Patrick Stiff; Jiang Zhu; Jiwang Zhang
Journal:  Haematologica       Date:  2016-09-15       Impact factor: 9.941

3.  Immune suppression for childhood acquired aplastic anemia and myelodysplastic syndrome: where next?

Authors:  Sujith Samarasinghe; Judith Marsh; Carlo Dufour
Journal:  Haematologica       Date:  2014-04       Impact factor: 9.941

4.  IFN-γ causes aplastic anemia by altering hematopoietic stem/progenitor cell composition and disrupting lineage differentiation.

Authors:  Fan-ching Lin; Megan Karwan; Bahara Saleh; Deborah L Hodge; Tim Chan; Kimberly C Boelte; Jonathan R Keller; Howard A Young
Journal:  Blood       Date:  2014-10-23       Impact factor: 22.113

5.  Macrophage TNF-α licenses donor T cells in murine bone marrow failure and can be implicated in human aplastic anemia.

Authors:  Wanling Sun; Zhijie Wu; Zenghua Lin; Maile Hollinger; Jichun Chen; Xingmin Feng; Neal S Young
Journal:  Blood       Date:  2018-10-25       Impact factor: 22.113

6.  Aplastic anemia: immunosuppressive therapy in 2010.

Authors:  Antonio M Risitano; Fabiana Perna
Journal:  Pediatr Rep       Date:  2011-06-22

Review 7.  Genetic associations in acquired immune-mediated bone marrow failure syndromes: insights in aplastic anemia and chronic idiopathic neutropenia.

Authors:  Irene Mavroudi; Helen A Papadaki
Journal:  Clin Dev Immunol       Date:  2012-08-26

8.  Expression of Shelterin component POT1 is associated with decreased telomere length and immunity condition in humans with severe aplastic anemia.

Authors:  Ting Wang; Shu-chong Mei; Rong Fu; Hua-quan Wang; Zong-hong Shao
Journal:  J Immunol Res       Date:  2014-05-06       Impact factor: 4.493

Review 9.  Etanercept-associated transient bone marrow aplasia: a review of the literature and pathogenetic mechanisms.

Authors:  Natasha Kozak; Joshua Friedman; Ami Schattner
Journal:  Drugs R D       Date:  2014-06

Review 10.  Hematopoietic Stem Cell Regulation by Type I and II Interferons in the Pathogenesis of Acquired Aplastic Anemia.

Authors:  Julianne N P Smith; Vikramjit S Kanwar; Katherine C MacNamara
Journal:  Front Immunol       Date:  2016-08-29       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.